Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments

• Status: Completed
• Trial end date: 1969-12-31

Summary

The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with low-grade Non-Hodgkin's Lymphoma who have previously failed Rituxan treatments.

• Phase: Phase 2/Phase 3

Details

• Lead Sponsor: Chiron Corporation
• Treatments: Aldesleukin; Interleukin-2; Rituximab